BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 27631799)

  • 1. Identification and Characterization of SUMO-SIM Interactions.
    Husnjak K; Keiten-Schmitz J; Müller S
    Methods Mol Biol; 2016; 1475():79-98. PubMed ID: 27631799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Fluorescent In Vitro Assay to Investigate Paralog-Specific SUMO Conjugation.
    Eisenhardt N; Chaugule VK; Pichler A
    Methods Mol Biol; 2016; 1475():67-78. PubMed ID: 27631798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-Time Surface Plasmon Resonance (SPR) for the Analysis of Interactions Between SUMO Traps and Mono- or PolySUMO Moieties.
    Xolalpa W; Rodriguez MS; England P
    Methods Mol Biol; 2016; 1475():99-107. PubMed ID: 27631800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using Biotinylated SUMO-Traps to Analyze SUMOylated Proteins.
    Lang V; Da Silva-Ferrada E; Barrio R; Sutherland JD; Rodriguez MS
    Methods Mol Biol; 2016; 1475():109-21. PubMed ID: 27631801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Use of Multimeric Protein Scaffolds for Identifying Multi-SUMO Binding Proteins.
    Aguilar-Martínez E; Sharrocks AD
    Methods Mol Biol; 2016; 1475():195-204. PubMed ID: 27631807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human Regulatory Protein Ki-1/57 Is a Target of SUMOylation and Affects PML Nuclear Body Formation.
    Saito Â; Souza EE; Costa FC; Meirelles GV; Gonçalves KA; Santos MT; Bressan GC; McComb ME; Costello CE; Whelan SA; Kobarg J
    J Proteome Res; 2017 Sep; 16(9):3147-3157. PubMed ID: 28695742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a new small ubiquitin-like modifier (SUMO)-interacting motif in the E3 ligase PIASy.
    Kaur K; Park H; Pandey N; Azuma Y; De Guzman RN
    J Biol Chem; 2017 Jun; 292(24):10230-10238. PubMed ID: 28455449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production and Purification of Recombinant SUMOylated Proteins Using Engineered Bacteria.
    Brockly F; Piechaczyk M; Bossis G
    Methods Mol Biol; 2016; 1475():55-65. PubMed ID: 27631797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the Role of Paralog-Specific Sumoylation of HDAC1.
    Citro S; Chiocca S
    Methods Mol Biol; 2017; 1510():329-337. PubMed ID: 27761832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of Histone Deacetylases Sumoylation by Immunoprecipitation Techniques.
    Wagner T; Godmann M; Heinzel T
    Methods Mol Biol; 2017; 1510():339-351. PubMed ID: 27761833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In Vitro Characterization of Chain Depolymerization Activities of SUMO-Specific Proteases.
    Eckhoff J; Dohmen RJ
    Methods Mol Biol; 2016; 1475():123-35. PubMed ID: 27631802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The ubiquitin-proteasome system is a key component of the SUMO-2/3 cycle.
    Schimmel J; Larsen KM; Matic I; van Hagen M; Cox J; Mann M; Andersen JS; Vertegaal AC
    Mol Cell Proteomics; 2008 Nov; 7(11):2107-22. PubMed ID: 18565875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small Ubiquitin-like Modifier Alters IFN Response.
    Maarifi G; Maroui MA; Dutrieux J; Dianoux L; Nisole S; Chelbi-Alix MK
    J Immunol; 2015 Sep; 195(5):2312-24. PubMed ID: 26223657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Studies Reveal a Sequential Mode of Chain Processing by the Yeast SUMO (Small Ubiquitin-related Modifier)-specific Protease Ulp2.
    Eckhoff J; Dohmen RJ
    J Biol Chem; 2015 May; 290(19):12268-81. PubMed ID: 25833950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reconstitution of the Recombinant RanBP2 SUMO E3 Ligase Complex.
    Ritterhoff T; Das H; Hao Y; Sakin V; Flotho A; Werner A; Melchior F
    Methods Mol Biol; 2016; 1475():41-54. PubMed ID: 27631796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Label-Free Identification and Quantification of SUMO Target Proteins.
    Hendriks IA; Vertegaal AC
    Methods Mol Biol; 2016; 1475():171-93. PubMed ID: 27631806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive and negative regulation of APP amyloidogenesis by sumoylation.
    Li Y; Wang H; Wang S; Quon D; Liu YW; Cordell B
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):259-64. PubMed ID: 12506199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human SUMO fusion systems enhance protein expression and solubility.
    Wang Z; Li H; Guan W; Ling H; Wang Z; Mu T; Shuler FD; Fang X
    Protein Expr Purif; 2010 Oct; 73(2):203-8. PubMed ID: 20457256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assay methods for small ubiquitin-like modifier (SUMO)-SUMO-interacting motif (SIM) interactions in vivo and in vitro using a split-luciferase complementation system.
    Hirohama M; Voet AR; Ozawa T; Saitoh H; Nakao Y; Zhang KY; Ito A; Yoshida M
    Anal Biochem; 2014 Mar; 448():92-4. PubMed ID: 24333278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.